These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8471555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
    Pronzato P, Vaira F, Vigani A, Losardo P, Bertelli G.
    Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846
    [Abstract] [Full Text] [Related]

  • 5. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW.
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [Abstract] [Full Text] [Related]

  • 6. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y, Kitaoka A, Yagi T, Tokuka A, Ohsumi K.
    Hepatogastroenterology; 2001 Oct; 48(37):128-32. PubMed ID: 11268947
    [Abstract] [Full Text] [Related]

  • 7. Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.
    Jones DV, Winn RJ, Brown BW, Levy LB, Pugh RP, Wade JL, Gross HM, Pendergrass KB, Levin B, Abbruzzese JL.
    Cancer; 1995 Nov 15; 76(10):1709-14. PubMed ID: 8625038
    [Abstract] [Full Text] [Related]

  • 8. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group.
    J Clin Oncol; 1992 Jun 15; 10(6):904-11. PubMed ID: 1588370
    [Abstract] [Full Text] [Related]

  • 9. Sequential methotrexate--5-FU--leucovorin (MFL) in advanced colorectal cancer.
    Glimelius B, Ginman C, Graffman S, Påhlman L, Ståhle E.
    Eur J Cancer Clin Oncol; 1986 Mar 15; 22(3):295-300. PubMed ID: 3486768
    [Abstract] [Full Text] [Related]

  • 10. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Pérez JE, Rodríguez R, Cuevas MA, Alvarez LA.
    Am J Clin Oncol; 1991 Jun 15; 14(3):211-7. PubMed ID: 2031508
    [Abstract] [Full Text] [Related]

  • 11. Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.
    Tomlinson SK, Melin SA, Higgs V, White DR, Savage P, Case D, Blackstock AW.
    BMC Cancer; 2002 May 02; 2():9. PubMed ID: 11988109
    [Abstract] [Full Text] [Related]

  • 12. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
    Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK.
    J Clin Oncol; 1989 Oct 02; 7(10):1407-18. PubMed ID: 2476530
    [Abstract] [Full Text] [Related]

  • 13. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.
    J Clin Oncol; 1996 Aug 02; 14(8):2274-9. PubMed ID: 8708717
    [Abstract] [Full Text] [Related]

  • 14. Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens.
    Glimelius B, Hoffman K, Olafsdottir M, Påhlman L, Sjödén PO, Wennberg A.
    Eur J Cancer Clin Oncol; 1989 May 02; 25(5):829-35. PubMed ID: 2472275
    [Abstract] [Full Text] [Related]

  • 15. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P.
    Cancer Chemother Pharmacol; 1996 May 02; 38(3):292-7. PubMed ID: 8646806
    [Abstract] [Full Text] [Related]

  • 16. Postsurgical sequential methotrexate, fluorouracil, and leucovorin for advanced colorectal carcinoma: a preliminary study.
    Tokunaga Y, Hata K, Nishitai R, Kaganoi J, Nanbu H, Ohsumi K.
    J Surg Oncol; 1997 Sep 02; 66(1):45-50. PubMed ID: 9290692
    [Abstract] [Full Text] [Related]

  • 17. Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
    Sobrero A, Zaniboni A, Frassineti GL, Aschele C, Guglielmi A, Giuliani R, Ravaioli A, Lanfranco C, Caroti C, Arnoldi E, Barni S, Gallo L, Pessi MA, Turci D, Cortesi E, Grossi F, Frontini L, Piazza E, Bruzzi P, Labianca R.
    Ann Oncol; 2000 Nov 02; 11(11):1413-20. PubMed ID: 11142481
    [Abstract] [Full Text] [Related]

  • 18. Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens.
    Bremnes RM, Wist EA.
    Anticancer Res; 1996 Nov 02; 16(2):921-6. PubMed ID: 8687152
    [Abstract] [Full Text] [Related]

  • 19. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ, Mittelman A.
    J Clin Oncol; 1987 Oct 02; 5(10):1559-65. PubMed ID: 2443619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.